188 related articles for article (PubMed ID: 15525652)
21. Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression.
Murai S; Umemiya T; Seiki M; Harigaya K
Virchows Arch; 2004 Sep; 445(3):271-8. PubMed ID: 15517370
[TBL] [Abstract][Full Text] [Related]
22. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
[TBL] [Abstract][Full Text] [Related]
23. Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier.
Zhuge Y; Xu J
J Biol Chem; 2001 May; 276(19):16248-56. PubMed ID: 11340084
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells.
Rozanov DV; Deryugina EI; Ratnikov BI; Monosov EZ; Marchenko GN; Quigley JP; Strongin AY
J Biol Chem; 2001 Jul; 276(28):25705-14. PubMed ID: 11335709
[TBL] [Abstract][Full Text] [Related]
26. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
27. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
28. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors.
Uekita T; Gotoh I; Kinoshita T; Itoh Y; Sato H; Shiomi T; Okada Y; Seiki M
J Biol Chem; 2004 Mar; 279(13):12734-43. PubMed ID: 14718544
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
[TBL] [Abstract][Full Text] [Related]
30. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
31. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
Suenaga N; Mori H; Itoh Y; Seiki M
Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
[TBL] [Abstract][Full Text] [Related]
32. Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
Osenkowski P; Meroueh SO; Pavel D; Mobashery S; Fridman R
J Biol Chem; 2005 Jul; 280(28):26160-8. PubMed ID: 15901740
[TBL] [Abstract][Full Text] [Related]
33. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
[TBL] [Abstract][Full Text] [Related]
34. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.
Beliën AT; Paganetti PA; Schwab ME
J Cell Biol; 1999 Jan; 144(2):373-84. PubMed ID: 9922462
[TBL] [Abstract][Full Text] [Related]
35. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
36. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
37. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.
Van Meter TE; Broaddus WC; Rooprai HK; Pilkington GJ; Fillmore HL
Neuro Oncol; 2004 Jul; 6(3):188-99. PubMed ID: 15279711
[TBL] [Abstract][Full Text] [Related]
38. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
Oku N; Sasabe E; Ueta E; Yamamoto T; Osaki T
Cancer Res; 2006 May; 66(10):5251-7. PubMed ID: 16707450
[TBL] [Abstract][Full Text] [Related]
39. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
40. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines.
Nagakawa O; Murakami K; Yamaura T; Fujiuchi Y; Murata J; Fuse H; Saiki I
Cancer Lett; 2000 Jul; 155(2):173-9. PubMed ID: 10822133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
